Quick Answer
Beneficient reported Cash and Equivalents of $1.35 million for fiscal year 2025.
Beneficient Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.35M | -83.0% |
| 2024 | $7.91M | -9.3% |
| 2023 | $8.73M | -87.6% |
| 2022 | $70.59M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $7.87M | +89.6% | +60.5% |
| September 30, 2025 | $4.90M | +9.4% | -35.6% |
| June 30, 2025 | $7.61M | +73.0% | +465.5% |
| March 31, 2025 | $1.35M | -83.0% | -67.6% |
| December 31, 2024 | $4.15M | -63.1% | -7.4% |
| September 30, 2024 | $4.48M | +87.2% | +1.9% |
| June 30, 2024 | $4.40M | +43.9% | -44.4% |
| March 31, 2024 | $7.91M | -9.3% | -29.6% |
- Beneficient showed a decrease of -83.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, Beneficient’s cash and equivalents has declined by 98.1% (from $70.59 million to $1.35 million).
- The most recent figure is from Beneficient’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: